V16L (p.Val16Leu) variant of IFNAR1 (Interferon alpha/beta receptor 1)

V16L (p.Val16Leu) in IFNAR1 (Interferon alpha/beta receptor 1) is a missense change. Clinical records from EBI and UniProt describe it as uncertain significance. The available variant effect predictions contribute to a CATVariant prioritization score of 0.17 / 1. The record also includes population frequency data and structural context.

V16L (p.Val16Leu) variant details